125 related articles for article (PubMed ID: 17662308)
1. A comparison of dopaminergic cells from the human NTera2/D1 cell line transplanted into the hemiparkinsonian rat.
Newcomb JD; Janowski M; Zigova T; Saporta S; McGrogan MP; Sanberg PR; Willing AE
Life Sci; 2007 Jul; 81(6):441-8. PubMed ID: 17662308
[TBL] [Abstract][Full Text] [Related]
2. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
Baker KA; Hong M; Sadi D; Mendez I
Exp Neurol; 2000 Apr; 162(2):350-60. PubMed ID: 10739641
[TBL] [Abstract][Full Text] [Related]
3. Long distance selective fiber outgrowth of transplanted hNT neurons in white matter tracts of the adult rat brain.
Baker KA; Mendez I
J Comp Neurol; 2005 Jun; 486(4):318-30. PubMed ID: 15846787
[TBL] [Abstract][Full Text] [Related]
4. Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson's disease.
Kanaan NM; Collier TJ; Marchionini DM; McGuire SO; Fleming MF; Sortwell CE
Brain Res; 2006 Jan; 1068(1):221-9. PubMed ID: 16368081
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
6. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
7. Comparison of calcium-binding proteins expressed in cultured hNT neurons and hNT neurons transplanted into the rat striatum.
Saporta S; Willing AE; Zigova T; Daadi MM; Sanberg PR
Exp Neurol; 2001 Feb; 167(2):252-9. PubMed ID: 11161613
[TBL] [Abstract][Full Text] [Related]
8. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy.
Kakishita K; Elwan MA; Nakao N; Itakura T; Sakuragawa N
Exp Neurol; 2000 Sep; 165(1):27-34. PubMed ID: 10964482
[TBL] [Abstract][Full Text] [Related]
9. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
10. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
Ramos-Moreno T; Castillo CG; Martínez-Serrano A
Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
[TBL] [Abstract][Full Text] [Related]
11. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.
Ebert AD; Beres AJ; Barber AE; Svendsen CN
Exp Neurol; 2008 Jan; 209(1):213-23. PubMed ID: 18061591
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic trophism after intrastriatal injection of lentivirus-transferred GDNF in Parkinson rat model.
Sun B; Hui GZ; Guo LH; Reiser J
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):937-40. PubMed ID: 14515213
[TBL] [Abstract][Full Text] [Related]
13. Intrastriatal transplantation of rat adrenal chromaffin cells seeded on microcarrier beads promote long-term functional recovery in hemiparkinsonian rats.
Borlongan CV; Saporta S; Sanberg PR
Exp Neurol; 1998 Jun; 151(2):203-14. PubMed ID: 9628755
[TBL] [Abstract][Full Text] [Related]
14. Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat.
Kobayashi K; Yasuhara T; Agari T; Muraoka K; Kameda M; Ji Yuan W; Hayase H; Matsui T; Miyoshi Y; Shingo T; Date I
Brain Res; 2006 Aug; 1102(1):1-11. PubMed ID: 16806124
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of semaphorin3A for dopaminergic neurons.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wenji Y; Hishikawa T; Matsui T; Miyoshi Y; Kimura T; Borlongan CV; Date I
Neurosci Lett; 2005 Jul 1-8; 382(1-2):61-5. PubMed ID: 15911122
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic differentiation of grafted GFP transgenic neuroepithelial stem cells in the brain of a rat model of Parkinson's disease.
Sun J; Gao Q; Miller K; Wang X; Wang J; Liu W; Bao L; Zhang J; Zhang L; Poon WS; Gao Y
Neurosci Lett; 2007 Jun; 420(1):23-8. PubMed ID: 17499438
[TBL] [Abstract][Full Text] [Related]
17. Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease.
Sharma R; McMillan CR; Tenn CC; Niles LP
Brain Res; 2006 Jan; 1068(1):230-6. PubMed ID: 16375867
[TBL] [Abstract][Full Text] [Related]
18. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
20. Long term gene therapy of Parkinson's disease using immortalized rat glial cell line with tyrosine hydroxylase gene.
Zhuo M; Xu DH; Cao L; Xu LF; Yu FR; Zheng ZC; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1066-71. PubMed ID: 14673496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
